Both in Pharmaceuticals
Aclaris Therapeutics vs Gyre Therapeutics
Over the past year ACRS returned +175.0% and GYRE returned −2.4%; their daily moves had a correlation of 0.17.
ACRS +175.0% GYRE −2.4%Growth of $1, one year, split-adjusted
| Metric | ACRS | GYRE |
|---|---|---|
| Price | $5.28 | $7.32 |
| Market cap | $777.2M | $776.2M |
| Today | −2.76% | −2.27% |
| 1 month | −12.1% | +11.1% |
| 6 months | +51.3% | +7.0% |
| Year to date | +75.4% | +3.7% |
| 1 year | +165.3% | +2.2% |
| Revenue growth (YoY) | −8.3% | −2.1% |
| Gross margin | 86.6% | 92.4% |
| Net margin | −1320.1% | −40.1% |
| P/E (TTM) | — | — |
| Price / sales | 94.6× | 6.5× |
| Net cash | $91.6M | $74.8M |
| Dividend yield | — | — |
| Volatility (60d) | 56.9% | 46.8% |
| Short % of float | 13.2% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).